Mr Paul Cathcart MBBS, MD, FRCS (Urol)
Paul Cathcart works at the Centre for Experimental Cancer Medicine, Bart’s Cancer Institute and is one of the designated robotic pelvic cancer surgeons at UCLH. His principle interests lie in the diagnosis and management of men with suspected prostate cancer. Prior to taking up his current position he completed a robotic and uro-oncology fellowship in Melbourne Australia. Previously an NIHR Academic Clinical Lecturer at University College Hospital London, he combines a high volume robotic clinical practice with an active research programme. His research interests lie in evaluating outcomes after cancer treatment together with studying prostate cancer epidemiology. Paul’s research is carried out at the centre for experimental cancer medicine within the Barts Cancer Institute and at the Clinical Effectiveness Unit of the Royal College of Surgeons of England.
A selection of recent publications
Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: A pilot study. Cancer. 2012 Sep 1;118(17):4148-55. Ahmed HU, Cathcart P, McCartan N, Kirkham A, Allen C, Freeman A, Emberton M.
Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. M. J Urol. 2012 Sep;188(3):762-7. doi: 10.1016/j.juro.2012.04.107. Epub 2012 Jul 19. Barzell WE, Melamed MR, Cathcart P, Moore CM, Ahmed HU, Emberton
Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy. Cancer. 2012 Jun 15;118(12):3071-8 Uddin Ahmed H, Cathcart P, Chalasani V, Williams A, McCartan N, Freeman A, Kirkham A, Allen C, Chin J, Emberton M.